Celsion - 20 Year Stock Price History | CLSN

Historical daily share price chart and data for Celsion since 1999 adjusted for splits. The latest closing stock price for Celsion as of August 16, 2019 is 1.80.
  • The all-time high Celsion stock price is 8826.30, which is 490250% above the current share price.
  • The Celsion 52-week high stock price is 2.96, which is 64.4% above the current share price.
  • The Celsion 52-week low stock price is 1.36, which is 24.4% below the current share price.
  • The average Celsion stock price for the last 52 weeks is 2.13.
Celsion Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 2.0236 1.6700 2.4700 1.6400 1.8000 27.66%
2018 2.4829 2.8200 3.3200 1.3600 1.4100 -47.39%
2017 3.0274 4.4100 7.1400 1.2800 2.6800 -37.01%
2016 17.1642 27.0200 27.0200 4.2546 4.2546 -84.17%
2015 32.0880 33.4600 44.1000 23.1000 26.8800 -17.60%
2014 44.6002 56.8400 63.9800 32.0600 32.6200 -40.10%
2013 104.4598 522.2698 589.0498 48.1950 54.4600 -89.45%
2012 224.7951 108.3600 556.2898 103.3200 515.9698 381.76%
2011 177.4256 138.5999 266.4899 106.4700 107.1000 -17.07%
2010 213.8751 195.3062 342.7199 126.6299 129.1499 -37.31%
2009 214.4935 174.5099 326.3399 129.1499 206.0099 48.64%
2008 251.8814 204.7499 409.4998 125.9999 138.5999 -25.93%
2007 301.5540 152.4599 447.2998 147.4199 187.1099 56.32%
2006 203.6957 255.1499 367.2899 113.4000 119.7000 -53.09%
2005 354.4499 510.2998 548.0998 245.6999 255.1499 -52.63%
2004 809.3622 1200.1495 1719.8993 387.4498 538.6498 -56.49%
2003 779.2497 387.4498 1417.4994 377.9998 1237.9495 204.65%
2002 478.6498 699.2997 926.0996 321.2999 406.3498 -34.85%
2001 851.1093 1124.5496 2475.8990 387.4498 623.6998 -34.00%
2000 3184.0112 2834.9989 8826.2965 944.9996 944.9996 -65.99%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.039B $0.001B
Celsion is dedicated to the development and commercialization of oncology drugs including tumor-targeting treatments using focused heat energy in combination with heat activated drug delivery systems. Celsion has research, license or commercialization agreements with leading institutions such as the National Institutes of Health, Duke University Medical Center, University of Hong Kong, North Shore Long Island Jewish Health System.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $122.351B 13.94
Gilead Sciences (GILD) United States $79.964B 9.82
Celgene (CELG) United States $67.146B 10.39
Vertex Pharmaceuticals (VRTX) United States $47.536B 51.37
Biogen (BIIB) United States $42.733B 7.59
Illumina (ILMN) United States $42.067B 49.42
CSL (CSLLY) Australia $35.043B 0.00
Regeneron Pharmaceuticals (REGN) United States $32.603B 14.80
Alexion Pharmaceuticals (ALXN) United States $24.856B 13.10
Incyte (INCY) United States $17.876B 52.61
Exact Sciences (EXAS) United States $15.515B 0.00
SINO PHARMACEUT (SBMFF) China $15.039B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.729B 0.00
Seattle Genetics (SGEN) United States $12.808B 0.00
Genmab (GNMSF) Denmark $12.376B 62.91
Guardant Health (GH) United States $9.438B 0.00
Sarepta Therapeutics (SRPT) United States $9.289B 0.00
Alnylam Pharmaceuticals (ALNY) United States $8.973B 0.00
Galapagos (GLPG) Belgium $8.822B 0.00
QIAGEN (QGEN) Netherlands $7.800B 25.62
Bio-Techne Corp (TECH) United States $7.483B 51.72
BeiGene (BGNE) Cayman Islands $6.826B 0.00
Bluebird Bio (BLUE) United States $6.633B 0.00
Exelixis (EXEL) United States $6.579B 17.10
Amarin (AMRN) Ireland $5.412B 0.00
Horizon Pharma Public (HZNP) Ireland $5.034B 12.80
Ascendis Pharma (ASND) Denmark $4.822B 0.00
Repligen (RGEN) United States $4.774B 92.64
ARGENX SE-ADR (ARGX) Netherlands $4.379B 0.00
Moderna (MRNA) United States $4.345B 0.00
ACADIA Pharmaceuticals (ACAD) United States $4.278B 0.00
Blueprint Medicines (BPMC) United States $4.129B 0.00
China Biologic Products (CBPO) China $3.889B 24.27
Spark Therapeutics (ONCE) United States $3.871B 0.00
MorphoSys AG (MOR) Germany $3.793B 0.00
Mirati Therapeutics (MRTX) United States $3.620B 0.00
Alkermes (ALKS) Ireland $3.402B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.384B 0.00
Immunomedics (IMMU) United States $2.868B 0.00
Genomic Health (GHDX) United States $2.783B 52.20
Arena Pharmaceuticals (ARNA) United States $2.776B 5.97
Amicus Therapeutics (FOLD) United States $2.640B 0.00
NeoGenomics (NEO) United States $2.621B 140.22
CRISPR Therapeutics AG (CRSP) Switzerland $2.599B 0.00
Medicines (MDCO) United States $2.596B 0.00
MyoKardia (MYOK) United States $2.487B 0.00
Acceleron Pharma (XLRN) United States $2.424B 0.00
Halozyme Therapeutics (HALO) United States $2.382B 0.00
Reata Pharmaceuticals (RETA) United States $2.280B 0.00
Emergent Biosolutions (EBS) United States $2.252B 33.84
UniQure (QURE) Netherlands $2.154B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.093B 0.00
Cambrex (CBM) United States $2.016B 25.49
Akcea Therapeutics (AKCA) United States $1.980B 0.00
Zai Lab (ZLAB) China $1.960B 0.00
Myriad Genetics (MYGN) United States $1.873B 19.65
Ligand Pharmaceuticals (LGND) United States $1.805B 22.82
Denali Therapeutics (DNLI) United States $1.740B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.673B 0.00
Insmed (INSM) United States $1.481B 0.00
RA PHARMCTL INC (RARX) United States $1.383B 0.00
REGENXBIO (RGNX) United States $1.368B 0.00
AnaptysBio (ANAB) United States $1.331B 0.00
Coherus BioSciences (CHRS) United States $1.317B 0.00
Sangamo Therapeutics (SGMO) United States $1.313B 0.00
Editas Medicine (EDIT) United States $1.270B 0.00
Epizyme (EPZM) United States $1.249B 0.00
Fate Therapeutics (FATE) United States $1.214B 0.00
Athenex (ATNX) United States $1.190B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.186B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.182B 0.00
Innoviva (INVA) United States $1.162B 3.36
Zymeworks (ZYME) Canada $1.034B 0.00
Alector (ALEC) United States $1.022B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.982B 0.00
Twist Bioscience (TWST) United States $0.965B 0.00
Cara Therapeutics (CARA) United States $0.928B 0.00
Principia Biopharma (PRNB) United States $0.892B 465.13
Adverum Biotechnologies (ADVM) United States $0.864B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.853B 0.00
Intellia Therapeutics (NTLA) United States $0.845B 0.00
ANI Pharmaceuticals (ANIP) United States $0.829B 13.85
ZIOPHARM Oncology Inc (ZIOP) United States $0.823B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.809B 29.21
Arvinas (ARVN) United States $0.806B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.802B 0.00
Codexis (CDXS) United States $0.781B 0.00
Cytokineticsorporated (CYTK) United States $0.778B 0.00
Anika Therapeutics (ANIK) United States $0.775B 27.42
Retrophin (RTRX) United States $0.765B 0.00
WAVE Life Sciences (WVE) Singapore $0.732B 0.00
Pharming Group (PHGUF) Netherlands $0.730B 0.00
Vericel (VCEL) United States $0.720B 0.00
Stemline Therapeutics (STML) United States $0.670B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.666B 0.00
Zealand Pharma (ZLDPF) Denmark $0.664B 0.00
Zealand Pharma (ZEAL) Denmark $0.651B 7.55
Heska (HSKA) United States $0.569B 73.68
MiMedx (MDXG) United States $0.559B 0.00
DBV Technologies S.A (DBVT) France $0.542B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.516B 0.00
Cellectis S.A (CLLS) France $0.511B 0.00
Intra-Cellular Therapies (ITCI) United States $0.502B 0.00
Revance Therapeutics (RVNC) United States $0.500B 0.00
Precision BioSciences (DTIL) United States $0.474B 0.00
Syros Pharmaceuticals (SYRS) United States $0.470B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Mesoblast (MESO) Australia $0.460B 0.00
UROGEN PHARMA (URGN) United States $0.440B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.438B 0.00
CytomX Therapeutics (CTMX) United States $0.424B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.398B 0.00
BioDelivery Sciences (BDSI) United States $0.389B 0.00
Agenus (AGEN) United States $0.389B 0.00
PHARMA MAR SA (PHMMF) Spain $0.385B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.385B 0.00
Merus (MRUS) Netherlands $0.383B 0.00
Avid Bioservices (CDMO) United States $0.371B 0.00
Puma Biotechnology (PBYI) United States $0.365B 0.00
AC Immune SA (ACIU) Switzerland $0.363B 26.90
Gritstone Oncology (GRTS) United States $0.350B 0.00
Arcus Biosciences (RCUS) United States $0.338B 0.00
Bellus Health (BLUSF) Canada $0.325B 0.00
Kadmon Holdings (KDMN) United States $0.324B 0.00
Biofrontera AG (BFRA) Germany $0.323B 0.00
Scholar Rock Holding (SRRK) United States $0.318B 0.00
Theratechnologies (THERF) Canada $0.312B 0.00
Prothena (PRTA) Ireland $0.309B 0.00
Clovis Oncology (CLVS) United States $0.306B 0.00
Starpharma Holdings (SPHRY) Australia $0.305B 0.00
Albireo Pharma (ALBO) United States $0.297B 0.00
Sorrento Therapeutics (SRNE) United States $0.293B 0.00
PDL BioPharma (PDLI) United States $0.292B 7.53
Kindred Biosciences (KIN) United States $0.284B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.278B 0.00
Protagonist Therapeutics (PTGX) United States $0.269B 0.00
Geron (GERN) United States $0.266B 0.00
Dynavax Technologies (DVAX) United States $0.260B 0.00
Cellular Biomedicine (CBMG) United States $0.260B 0.00
Senesco Technologies (ELOX) United States $0.249B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.247B 0.00
ChromaDex (CDXC) United States $0.237B 0.00
Inovio Pharmaceuticals (INO) United States $0.235B 0.00
ADMA Biologics Inc (ADMA) United States $0.234B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.228B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.226B 0.00
Kamada (KMDA) Israel $0.214B 8.17
Five Prime Therapeutics (FPRX) United States $0.214B 0.00
PHASEBIO PHARMA (PHAS) United States $0.212B 0.00
Prometic Life Sciences (PFSCF) Canada $0.210B 0.00
Seres Therapeutics (MCRB) United States $0.208B 0.00
MannKind (MNKD) United States $0.207B 0.00
Athersys (ATHX) United States $0.202B 0.00
Sutro Biopharma (STRO) United States $0.199B 0.00
Compugen (CGEN) Israel $0.194B 0.00
Spero Therapeutics (SPRO) United States $0.189B 0.00
Novavax (NVAX) United States $0.188B 0.00
Cue Biopharma (CUE) United States $0.180B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.171B 0.00
Affimed (AFMD) Germany $0.170B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Dyadic (DYAI) United States $0.163B 0.00
POXEL SA FRANCE (PXXLF) $0.163B 0.00
Arsanis (XFOR) United States $0.163B 0.00
Emmaus Life Sciences (EMMA) United States $0.156B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.155B 0.00
OSMOTICA PHARM (OSMT) United States $0.155B 0.00
Enzo Biochem (ENZ) United States $0.153B 0.00
Cerecor (CERC) United States $0.151B 0.00
Alcobra (ARCT) United States $0.151B 0.00
XOMA (XOMA) United States $0.149B 0.00
Nicox SA (NICXF) France $0.147B 0.00
Synlogic (SYBX) United States $0.146B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.146B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.142B 0.00
Adocia (ADOCY) France $0.140B 0.00
Strongbridge Biopharma (SBBP) United States $0.137B 5.62
Acorda Therapeutics (ACOR) United States $0.130B 0.00
Mersana Therapeutics (MRSN) United States $0.130B 0.00
Northwest Biotherapeutics (NWBO) United States $0.125B 0.00
Windtree Therapeutics (WINT) United States $0.125B 0.00
NantKwest (NK) United States $0.123B 0.00
Celyad SA (CYAD) Belgium $0.121B 0.00
SESEN BIO, INC (SESN) United States $0.113B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.113B 0.00
Liquidia Technologies (LQDA) United States $0.112B 0.00
Aduro Biotech (ADRO) United States $0.111B 0.00
Fortress Biotech (FBIO) United States $0.110B 0.00
Abeona Therapeutics (ABEO) United States $0.109B 0.00
Aptinyx (APTX) United States $0.108B 0.00
TOCAGEN INC (TOCA) United States $0.108B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.107B 0.00
Checkpoint Therapeutics (CKPT) United States $0.104B 0.00
Verastem (VSTM) United States $0.095B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.094B 0.00
OvaScience (MLND) United States $0.094B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.092B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.087B 0.00
Arbutus Biopharma (ABUS) Canada $0.085B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.085B 0.00
Catalyst Biosciences (CBIO) United States $0.083B 0.00
Menlo Therapeutics (MNLO) United States $0.082B 0.00
Trevena (TRVN) United States $0.082B 0.00
Selecta Biosciences (SELB) United States $0.082B 0.00
Vaccinex (VCNX) United States $0.074B 0.00
Orgenesis (ORGS) United States $0.073B 0.00
VTv Therapeutics (VTVT) United States $0.071B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.071B 0.00
ARAVIVE, INC (ARAV) United States $0.071B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.069B 0.00
VBI Vaccines (VBIV) United States $0.067B 0.00
Curis (CRIS) United States $0.067B 0.00
AquaBounty Technologies (AQB) United States $0.067B 0.00
Antibe Therapeutics (ATBPF) Canada $0.065B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.064B 0.00
Idera Pharmaceuticals (IDRA) United States $0.061B 0.00
Unum Therapeutics (UMRX) United States $0.061B 0.00
NewLink Genetics (NLNK) United States $0.058B 0.00
Prima BioMed (IMMP) Australia $0.057B 0.00
Oncobiologics (OTLK) United States $0.056B 0.00
Applied Genetic Technologies (AGTC) United States $0.056B 30.80
Pluristem Therapeutics (PSTI) Israel $0.055B 0.00
AIT Therapeutics (XAIR) United States $0.055B 0.00
China Health Industries Holdings (CHHE) China $0.054B 20.47
Ophthotech (ISEE) United States $0.045B 0.00
Clearside Biomedical (CLSD) United States $0.045B 0.00
Vascular Biogenics (VBLT) Israel $0.042B 0.00
Evogene (EVGN) Israel $0.040B 0.00
Organovo Holdings (ONVO) United States $0.038B 0.00
Apricus Biosciences (SEEL) United States $0.036B 0.00
Alimera Sciences (ALIM) United States $0.035B 0.00
Aptevo Therapeutics (APVO) United States $0.035B 0.00
AEterna Zentaris (AEZS) United States $0.035B 0.00
VIVUS (VVUS) United States $0.034B 0.00
Proteostasis Therapeutics (PTI) United States $0.034B 0.00
Celldex Therapeutics (CLDX) United States $0.033B 0.00
BIOCARDIA INC (BCDA) United States $0.032B 0.00
DiaMedica Therapeutics (DMAC) United States $0.031B 0.00
Entera Bio (ENTX) Israel $0.029B 0.20
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.029B 0.00
Signal Genetics (MGEN) United States $0.028B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.026B 0.00
Caladrius Biosciences (CLBS) United States $0.024B 0.00
Soligenix (SNGX) United States $0.022B 0.00
Aytu Bioscience (AYTU) United States $0.022B 0.00
VistaGen Therapeutics (VTGN) United States $0.022B 0.00
Vical (VICL) United States $0.020B 0.00
Bionano Genomics (BNGO) United States $0.020B 0.00
Fibrocell Science Inc (FCSC) United States $0.018B 6.07
TRACON Pharmaceuticals (TCON) United States $0.016B 0.00
Cleveland BioLabs (CBLI) United States $0.016B 0.00
Pulmatrix (PULM) United States $0.016B 0.00
Novogen (KZIA) Australia $0.015B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
CollPlant Holdings (CLGN) Israel $0.014B 0.00
Novelion Therapeutics (NVLN) Canada $0.013B 0.00
TrovaGene (TROV) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.008B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
Advaxis (ADXS) United States $0.007B 0.00
Stellar Biotechnologies (EDSA) Canada $0.004B 0.00
Neuralstem (CUR) United States $0.002B 0.00
Bio-Rad Laboratories (BIO.B) United States $0.000B 0.00